The interferon story continues: EORTC CLTG study explores pegylated interferon alpha-2a's role in treating mycosis fungoides/Sezary syndrome. Stadler R. Br J Dermatol 2024;191:321-322.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stadler R. The interferon story continues: EORTC CLTG study explores pegylated interferon alpha-2a's role in treating mycosis fungoides/Sezary syndrome. Br J Dermatol 2024;191:321-322.
PMID: 38703059